VWF and thrombotic thrombocytopenic purpura: In mouse models of congenital TTP, in which ADAMTS13−/− mice are challenged with recombinant VWF 84, the administration of recombinant ADAMTS‐13 (rADAMTS‐13) ameliorates TTP.